HEADER TRANSFERASE/TRANSFERASE INHIBITOR 06-AUG-12 4GG7 TITLE CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HGF RECEPTOR, HGF/SF RECEPTOR, PROTO-ONCOGENE C-MET, SCATTER COMPND 5 FACTOR RECEPTOR, SF RECEPTOR, TYROSINE-PROTEIN KINASE MET; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CMET, MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS C-MET INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Q.F.LIU,T.T.CHEN,Y.C.XU REVDAT 3 28-FEB-24 4GG7 1 REMARK SEQADV REVDAT 2 17-OCT-12 4GG7 1 JRNL REVDAT 1 03-OCT-12 4GG7 0 JRNL AUTH K.WU,J.AI,Q.LIU,T.CHEN,A.ZHAO,X.PENG,Y.WANG,Y.JI,Q.YAO,Y.XU, JRNL AUTH 2 M.GENG,A.ZHANG JRNL TITL MULTISUBSTITUTED QUINOXALINES AND PYRIDO[2,3-D]PYRIMIDINES: JRNL TITL 2 SYNTHESIS AND SAR STUDY AS TYROSINE KINASE C-MET INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 6368 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22985853 JRNL DOI 10.1016/J.BMCL.2012.08.075 REMARK 2 REMARK 2 RESOLUTION. 2.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8_1069 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.15 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 19514 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1952 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.1526 - 5.4649 0.98 1398 156 0.2315 0.2652 REMARK 3 2 5.4649 - 4.3396 1.00 1328 147 0.1754 0.2266 REMARK 3 3 4.3396 - 3.7916 1.00 1306 145 0.1716 0.2300 REMARK 3 4 3.7916 - 3.4452 1.00 1285 144 0.1879 0.2304 REMARK 3 5 3.4452 - 3.1984 1.00 1274 142 0.2019 0.2836 REMARK 3 6 3.1984 - 3.0099 1.00 1263 139 0.2090 0.2423 REMARK 3 7 3.0099 - 2.8592 1.00 1269 142 0.2160 0.2816 REMARK 3 8 2.8592 - 2.7348 1.00 1264 140 0.2173 0.2958 REMARK 3 9 2.7348 - 2.6295 0.96 1200 133 0.2128 0.2894 REMARK 3 10 2.6295 - 2.5388 0.96 1206 135 0.2214 0.3161 REMARK 3 11 2.5388 - 2.4594 0.97 1212 134 0.2218 0.3146 REMARK 3 12 2.4594 - 2.3891 0.97 1217 135 0.2318 0.3104 REMARK 3 13 2.3891 - 2.3263 0.97 1209 135 0.2338 0.2891 REMARK 3 14 2.3263 - 2.2700 0.92 1131 125 0.2494 0.3146 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.010 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.28 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.77 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2321 REMARK 3 ANGLE : 1.134 3144 REMARK 3 CHIRALITY : 0.079 342 REMARK 3 PLANARITY : 0.005 393 REMARK 3 DIHEDRAL : 16.836 860 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4GG7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000074142. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19514 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270 REMARK 200 RESOLUTION RANGE LOW (A) : 38.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.17500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.27 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.73400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.340 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL, 15% GLYCEROL, 12% MPD, REMARK 280 5% ISOPROPANOL, 14% PEG5000, PH 7.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 93.58800 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 32.93350 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 32.93350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 46.79400 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 32.93350 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 32.93350 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 140.38200 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 32.93350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 32.93350 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 46.79400 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 32.93350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 32.93350 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 140.38200 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 93.58800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1028 REMARK 465 GLY A 1029 REMARK 465 SER A 1030 REMARK 465 SER A 1031 REMARK 465 HIS A 1032 REMARK 465 HIS A 1033 REMARK 465 HIS A 1034 REMARK 465 HIS A 1035 REMARK 465 HIS A 1036 REMARK 465 HIS A 1037 REMARK 465 GLY A 1038 REMARK 465 ASP A 1039 REMARK 465 SER A 1040 REMARK 465 ASP A 1041 REMARK 465 ILE A 1042 REMARK 465 SER A 1043 REMARK 465 SER A 1044 REMARK 465 PRO A 1045 REMARK 465 LEU A 1046 REMARK 465 LEU A 1047 REMARK 465 GLN A 1048 REMARK 465 ASN A 1049 REMARK 465 THR A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 ASP A 1054 REMARK 465 LEU A 1055 REMARK 465 SER A 1056 REMARK 465 ALA A 1057 REMARK 465 LEU A 1058 REMARK 465 ASN A 1059 REMARK 465 PRO A 1060 REMARK 465 GLU A 1061 REMARK 465 LEU A 1062 REMARK 465 VAL A 1063 REMARK 465 ILE A 1115 REMARK 465 THR A 1116 REMARK 465 ASP A 1117 REMARK 465 ILE A 1345 REMARK 465 GLY A 1346 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A1064 CG CD OE1 NE2 REMARK 470 SER A1152 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A1065 -14.45 75.62 REMARK 500 GLU A1082 79.04 -110.27 REMARK 500 ASP A1099 -176.32 -68.18 REMARK 500 HIS A1136 146.44 -170.85 REMARK 500 ARG A1203 -19.01 85.25 REMARK 500 ASP A1204 46.34 -143.53 REMARK 500 ALA A1221 -141.82 -116.60 REMARK 500 THR A1343 -153.59 -92.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0J8 A 1401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4GG5 RELATED DB: PDB DBREF 4GG7 A 1038 1346 UNP P08581 MET_HUMAN 1038 1346 SEQADV 4GG7 MET A 1028 UNP P08581 EXPRESSION TAG SEQADV 4GG7 GLY A 1029 UNP P08581 EXPRESSION TAG SEQADV 4GG7 SER A 1030 UNP P08581 EXPRESSION TAG SEQADV 4GG7 SER A 1031 UNP P08581 EXPRESSION TAG SEQADV 4GG7 HIS A 1032 UNP P08581 EXPRESSION TAG SEQADV 4GG7 HIS A 1033 UNP P08581 EXPRESSION TAG SEQADV 4GG7 HIS A 1034 UNP P08581 EXPRESSION TAG SEQADV 4GG7 HIS A 1035 UNP P08581 EXPRESSION TAG SEQADV 4GG7 HIS A 1036 UNP P08581 EXPRESSION TAG SEQADV 4GG7 HIS A 1037 UNP P08581 EXPRESSION TAG SEQRES 1 A 319 MET GLY SER SER HIS HIS HIS HIS HIS HIS GLY ASP SER SEQRES 2 A 319 ASP ILE SER SER PRO LEU LEU GLN ASN THR VAL HIS ILE SEQRES 3 A 319 ASP LEU SER ALA LEU ASN PRO GLU LEU VAL GLN ALA VAL SEQRES 4 A 319 GLN HIS VAL VAL ILE GLY PRO SER SER LEU ILE VAL HIS SEQRES 5 A 319 PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE GLY CYS VAL SEQRES 6 A 319 TYR HIS GLY THR LEU LEU ASP ASN ASP GLY LYS LYS ILE SEQRES 7 A 319 HIS CYS ALA VAL LYS SER LEU ASN ARG ILE THR ASP ILE SEQRES 8 A 319 GLY GLU VAL SER GLN PHE LEU THR GLU GLY ILE ILE MET SEQRES 9 A 319 LYS ASP PHE SER HIS PRO ASN VAL LEU SER LEU LEU GLY SEQRES 10 A 319 ILE CYS LEU ARG SER GLU GLY SER PRO LEU VAL VAL LEU SEQRES 11 A 319 PRO TYR MET LYS HIS GLY ASP LEU ARG ASN PHE ILE ARG SEQRES 12 A 319 ASN GLU THR HIS ASN PRO THR VAL LYS ASP LEU ILE GLY SEQRES 13 A 319 PHE GLY LEU GLN VAL ALA LYS GLY MET LYS TYR LEU ALA SEQRES 14 A 319 SER LYS LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 15 A 319 CYS MET LEU ASP GLU LYS PHE THR VAL LYS VAL ALA ASP SEQRES 16 A 319 PHE GLY LEU ALA ARG ASP MET TYR ASP LYS GLU TYR TYR SEQRES 17 A 319 SER VAL HIS ASN LYS THR GLY ALA LYS LEU PRO VAL LYS SEQRES 18 A 319 TRP MET ALA LEU GLU SER LEU GLN THR GLN LYS PHE THR SEQRES 19 A 319 THR LYS SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP SEQRES 20 A 319 GLU LEU MET THR ARG GLY ALA PRO PRO TYR PRO ASP VAL SEQRES 21 A 319 ASN THR PHE ASP ILE THR VAL TYR LEU LEU GLN GLY ARG SEQRES 22 A 319 ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP PRO LEU TYR SEQRES 23 A 319 GLU VAL MET LEU LYS CYS TRP HIS PRO LYS ALA GLU MET SEQRES 24 A 319 ARG PRO SER PHE SER GLU LEU VAL SER ARG ILE SER ALA SEQRES 25 A 319 ILE PHE SER THR PHE ILE GLY HET 0J8 A1401 36 HETNAM 0J8 N-(3-NITROBENZYL)-6-[1-(PIPERIDIN-4-YL)-1H-PYRAZOL-4- HETNAM 2 0J8 YL]-2-(TRIFLUOROMETHYL)PYRIDO[2,3-D]PYRIMIDIN-4-AMINE FORMUL 2 0J8 C23 H21 F3 N8 O2 FORMUL 3 HOH *133(H2 O) HELIX 1 1 VAL A 1066 VAL A 1070 5 5 HELIX 2 2 GLY A 1072 SER A 1074 5 3 HELIX 3 3 GLU A 1120 PHE A 1134 1 15 HELIX 4 4 ASP A 1164 ASN A 1171 1 8 HELIX 5 5 THR A 1177 LYS A 1198 1 22 HELIX 6 6 ALA A 1206 ARG A 1208 5 3 HELIX 7 7 PHE A 1223 ARG A 1227 5 5 HELIX 8 8 ASP A 1231 TYR A 1235 5 5 HELIX 9 9 PRO A 1246 MET A 1250 5 5 HELIX 10 10 ALA A 1251 GLN A 1258 1 8 HELIX 11 11 THR A 1261 THR A 1278 1 18 HELIX 12 12 ASP A 1291 GLN A 1298 1 8 HELIX 13 13 PRO A 1309 TRP A 1320 1 12 HELIX 14 14 LYS A 1323 ARG A 1327 5 5 HELIX 15 15 SER A 1329 THR A 1343 1 15 SHEET 1 A 5 LEU A1076 GLY A1087 0 SHEET 2 A 5 GLY A1090 LEU A1098 -1 O THR A1096 N ILE A1077 SHEET 3 A 5 LYS A1104 LEU A1112 -1 O VAL A1109 N TYR A1093 SHEET 4 A 5 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 5 A 5 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156 SHEET 1 B 2 CYS A1210 LEU A1212 0 SHEET 2 B 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 C 2 SER A1236 VAL A1237 0 SHEET 2 C 2 LYS A1244 LEU A1245 -1 O LEU A1245 N SER A1236 SITE 1 AC1 16 ILE A1084 ALA A1108 LEU A1140 LEU A1157 SITE 2 AC1 16 PRO A1158 TYR A1159 MET A1160 LYS A1161 SITE 3 AC1 16 ARG A1208 ASN A1209 MET A1211 ALA A1221 SITE 4 AC1 16 ASP A1222 ALA A1226 TYR A1230 HOH A1521 CRYST1 65.867 65.867 187.176 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015182 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015182 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005343 0.00000